Type I interferon signaling promotes radioresistance in head and neck cancer Translational Cancer Research 2024;13(5):2535-2543
Date
01/01/2024DOI
10.21037/tcr-23-2104Scopus ID
2-s2.0-85195040296 (requires institutional sign-in at Scopus site) 1 CitationAuthor List
Zenga J, Awan MJ, Frei A, Massey B, Bruening J, Shukla M, Sharma GP, Shreenivas A, Wong SJ, Zimmermann MT, Mathison AJ, Himburg HAAuthors
Musaddiq J. Awan MD Associate Professor in the Radiation Oncology department at Medical College of WisconsinAngela Mathison PhD Assistant Professor in the Surgery department at Medical College of Wisconsin
Monica E. Shukla MD Associate Professor in the Radiation Oncology department at Medical College of Wisconsin
Joseph Zenga MD Associate Professor in the Otolaryngology department at Medical College of Wisconsin
Michael T. Zimmermann PhD Director, Assistant Professor in the Clinical and Translational Science Institute department at Medical College of Wisconsin